Redian新闻
>
ECYT这把套住了不少人吧?
avatar
ECYT这把套住了不少人吧?# Stock
h*n
1
戴神号召的时候6.7 不过每股才亏4毛钱,过两天就回去了
avatar
l*t
2
7.66买的肿么办啊。。。。

【在 h****n 的大作中提到】
: 戴神号召的时候6.7 不过每股才亏4毛钱,过两天就回去了
avatar
f*s
3
这个股是等死的节奏。。。
avatar
l*x
4
能short么?
avatar
p*p
5
ecyt有$5.4 cash per share.
avatar
l*i
6
肺癌的IIb期结果挺怪异的,他们用的P值我不懂,我只知道小于0.05才是有统计学
差异
In the phase IIb lung cancer study, the combination of vintafolide and
docetaxel met the primary endpoint of progression-free survival with a p
value of 0.0696. Endocyte uses a more forgiving statistical hurdle in the
phase II than you'd typically see in a large phase II study, which explains
why a p value of greater than 0.05 was considered statistically significant.

【在 p****p 的大作中提到】
: ecyt有$5.4 cash per share.
avatar
x*u
7
under 0.1, not so bad.

explains
significant.

【在 l********i 的大作中提到】
: 肺癌的IIb期结果挺怪异的,他们用的P值我不懂,我只知道小于0.05才是有统计学
: 差异
: In the phase IIb lung cancer study, the combination of vintafolide and
: docetaxel met the primary endpoint of progression-free survival with a p
: value of 0.0696. Endocyte uses a more forgiving statistical hurdle in the
: phase II than you'd typically see in a large phase II study, which explains
: why a p value of greater than 0.05 was considered statistically significant.

avatar
z*i
8
做统计就是要学怎么忽悠人。呵呵。

explains
significant.

【在 l********i 的大作中提到】
: 肺癌的IIb期结果挺怪异的,他们用的P值我不懂,我只知道小于0.05才是有统计学
: 差异
: In the phase IIb lung cancer study, the combination of vintafolide and
: docetaxel met the primary endpoint of progression-free survival with a p
: value of 0.0696. Endocyte uses a more forgiving statistical hurdle in the
: phase II than you'd typically see in a large phase II study, which explains
: why a p value of greater than 0.05 was considered statistically significant.

avatar
l*i
9
另外,他们这个II期是open-label,会不会MRK已经知道了OS的结果后放弃的

explains
significant.

【在 l********i 的大作中提到】
: 肺癌的IIb期结果挺怪异的,他们用的P值我不懂,我只知道小于0.05才是有统计学
: 差异
: In the phase IIb lung cancer study, the combination of vintafolide and
: docetaxel met the primary endpoint of progression-free survival with a p
: value of 0.0696. Endocyte uses a more forgiving statistical hurdle in the
: phase II than you'd typically see in a large phase II study, which explains
: why a p value of greater than 0.05 was considered statistically significant.

avatar
p*p
10
One-tailed test. LOL
这个p value是烂。病人数又不多。

explains
significant.

【在 l********i 的大作中提到】
: 肺癌的IIb期结果挺怪异的,他们用的P值我不懂,我只知道小于0.05才是有统计学
: 差异
: In the phase IIb lung cancer study, the combination of vintafolide and
: docetaxel met the primary endpoint of progression-free survival with a p
: value of 0.0696. Endocyte uses a more forgiving statistical hurdle in the
: phase II than you'd typically see in a large phase II study, which explains
: why a p value of greater than 0.05 was considered statistically significant.

avatar
p*p
11
你说肺癌这个是open-label?

【在 l********i 的大作中提到】
: 另外,他们这个II期是open-label,会不会MRK已经知道了OS的结果后放弃的
:
: explains
: significant.

avatar
l*i
12
AF原文里是0.696,我改过了

【在 p****p 的大作中提到】
: One-tailed test. LOL
: 这个p value是烂。病人数又不多。
:
: explains
: significant.

avatar
l*i
13
是的。
现在唯一的盼头就是这个OS结果了,结果好还能继续,不好就完了。鉴于PFS的P值才这
么多,我怀疑OS不会好。
这公司挺差劲的,上次两个好消息一起公布,股价飞天,马上增发,之后再腰斩了,但
钱到手了,这种消息不可能一天得到,肯定是憋着不发。估计这个OS的结果也会憋很久
才出来。

【在 p****p 的大作中提到】
: 你说肺癌这个是open-label?
avatar
b*r
14
p value到0.0695就很不错了,2期的病人量不多。
相关阅读
logo
联系我们隐私协议©2024 redian.news
Redian新闻
Redian.news刊载任何文章,不代表同意其说法或描述,仅为提供更多信息,也不构成任何建议。文章信息的合法性及真实性由其作者负责,与Redian.news及其运营公司无关。欢迎投稿,如发现稿件侵权,或作者不愿在本网发表文章,请版权拥有者通知本网处理。